John Cox is a global biotechnology and biopharma executive recognized for building and leading high-growth businesses and management teams. Currently serving as the CEO of Dyne Therapeutics, John has a proven track record of creating corporate strategies, negotiating innovative business deals, and driving shareholder value. Their previous experience includes serving as CEO of Bioverativ, where John successfully orchestrated a sale to Sanofi that generated significant value for investors. Additionally, John has held prominent roles at Biogen and contributed as an executive leader in various biotech firms, including as Executive Chairman of Minovia Therapeutics. John earned an MBA in Finance from the University of Michigan's Stephen M. Ross School of Business.
This person is not in the org chart
This person is not in any teams
This person is not in any offices